Inflammatory and non-inflammatory roles for toll-like receptors in gastrointestinal cancer

Current Pharmaceutical Design

Volumn 21, Issue 21, 2015, Pages 2968-2977

  West, Alison C ^a   Jenkins, Brendan J ^a  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Barrett s esophagus; Cox 2; Gastrointestinal cancer; Helicobacter pylori; Inflammatory bowel disease; Intestinal homeostasis; Tolllike receptors; Tumor cell apoptosis; Tumor cell proliferation

Indexed keywords

TOLL LIKE RECEPTOR;

APOPTOSIS; ARTICLE; BARRETT ESOPHAGUS; CANCER RESEARCH; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL PROLIFERATION; CHRONIC INFLAMMATION; COLITIS; DIGESTIVE SYSTEM CANCER; DIGESTIVE SYSTEM INFLAMMATION; DISEASE ASSOCIATION; ESOPHAGUS CANCER; GASTROINTESTINAL TRACT; HELICOBACTER PYLORI; HOMEOSTASIS; HOST RESISTANCE; HUMAN; IMMUNE SYSTEM; INFLAMMATORY BOWEL DISEASE; INTESTINE CANCER; INTESTINE EPITHELIUM; INTESTINE FLORA; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STOMACH CANCER; TISSUE REPAIR; ANIMAL; GASTROENTERITIS; GASTROINTESTINAL TUMOR; GENETICS; PATHOLOGY;

ANIMALS; GASTROENTERITIS; GASTROINTESTINAL NEOPLASMS; HUMANS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84931858395     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612821666150514104411     Document Type: Article

References (129)

1. Koblansky AA, Jankovic D, Oh H, et al. Recognition of profilin by Toll-like receptor 12 is critical for host resistance to Toxoplasma gondii. Immunity 2013; 38(1): 119-30.
2. Oldenburg M, Kruger A, Ferstl R, et al. TLR13 recognizes bacterial 23S rRNA devoid of erythromycin resistance-forming modification. Science 2012; 337(6098): 1111-5.
3. Broz P, Monack DM. Newly described pattern recognition receptors team up against intracellular pathogens. Nat Rev Immunol 2013; 13(8): 551-65.
4. Stewart CR, Stuart LM, Wilkinson K, et al. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat Immunol 2010; 11(2): 155-61.
5. Mollen KP, Anand RJ, Tsung A, et al. Emerging paradigm: tolllike receptor 4-sentinel for the detection of tissue damage. Shock (Augusta, Ga) 2006; 26(5): 430-7.
6. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010; 11(5): 373-84.
7. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004; 4(7): 499-511.
8. Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001; 2(8): 675-80.
9. Takeda K, Kaisho T, Akira S. Toll-like receptors. Ann Rev Immunol 2003; 21: 335-76.
10. Artis D. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat Rev Immunol 2008; 8(6): 411-20.
11. Treiner E, Duban L, Bahram S, et al. Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1. Nature 2003; 422(6928): 164-9.
12. Coombes JL, Powrie F. Dendritic cells in intestinal immune regulation. Nat Rev Immunol 2008; 8(6): 435-46.
13. Lim DM, Narasimhan S, Michaylira CZ, et al. TLR3-mediated NF- {kappa}B signaling in human esophageal epithelial cells. Am J Physiol Gastrointestinal Liver Physiol 2009; 297(6): G1172-80.
14. Verbeek RE, Siersema PD, Ten Kate FJ, et al. Toll-like receptor 4 activation in Barrett's esophagus results in a strong increase in COX-2 expression. J Gastroenterol 2014; 49(7): 1121-34.
15. Pimentel-Nunes P, Afonso L, Lopes P, et al. Increased expression of toll-like receptors (TLR) 2, 4 and 5 in gastric dysplasia. Pathol Oncol Res 2011; 17(3): 677-83.
16. Schmausser B, Andrulis M, Endrich S, et al. Expression and subcellular distribution of toll-like receptors TLR4, TLR5 and TLR9 on the gastric epithelium in Helicobacter pylori infection. Clin Exp Immunol 2004; 136(3): 521-6.
17. Abreu MT, Vora P, Faure E, et al. Decreased expression of Tolllike receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. J Immunol (Baltimore, Md: 1950) 2001; 167(3): 1609-16.
18. Cario E, Podolsky DK. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 2000; 68(12): 7010-7.
19. Furrie E, Macfarlane S, Thomson G, et al. Toll-like receptors-2, -3 and -4 expression patterns on human colon and their regulation by mucosal-associated bacteria. Immunology 2005; 115(4): 565-74.
20. Melmed G, Thomas LS, Lee N, et al. Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut. J Immunol 2003; 170(3): 1406-15.
21. Abreu MT. Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat Rev Immunol 2010; 10(2): 131-44.
22. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, et al. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004; 118(2): 229-41.
23. Abreu MT, Arnold ET, Thomas LS, et al. TLR4 and MD-2 expression is regulated by immune-mediated signals in human intestinal epithelial cells. J Biol Chem 2002; 277(23): 20431-7.
24. Suzuki M, Hisamatsu T, Podolsky DK. Gamma interferon augments the intracellular pathway for lipopolysaccharide (LPS) recognition in human intestinal epithelial cells through coordinated up-regulation of LPS uptake and expression of the intracellular Toll-like receptor 4-MD-2 complex. Infect Immun 2003; 71(6): 3503-11.
25. Wald D, Qin J, Zhao Z, et al. SIGIRR, a negative regulator of Tolllike receptor-interleukin 1 receptor signaling. Nat Immunol 2003; 4(9): 920-7.
26. Garlanda C, Riva F, Polentarutti N, et al. Intestinal inflammation in mice deficient in Tir8, an inhibitory member of the IL-1 receptor family. Proc Natl Acad Sci USA 2004; 101(10): 3522-6.
27. Xiao H, Gulen MF, Qin J, et al. The Toll-interleukin-1 receptor member SIGIRR regulates colonic epithelial homeostasis, inflammation, and tumorigenesis. Immunity 2007; 26(4): 461-75.
28. Otte JM, Cario E, Podolsky DK. Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells. Gastroenterology 2004; 126(4): 1054-70.
29. Venkatesh M, Mukherjee S, Wang H, et al. Symbiotic bacterial metabolites regulate gastrointestinal barrier function via the xenobiotic sensor PXR and Toll-like receptor 4. Immunity 2014; 41(2): 296-310.
30. Gewirtz AT, Navas TA, Lyons S, et al. Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J Immunol (Baltimore, Md: 1950) 2001; 167(4): 1882-5.
31. Gewirtz AT, Simon PO, Jr., Schmitt CK, et al. Salmonella typhimurium translocates flagellin across intestinal epithelia, inducing a proinflammatory response. J Clin Invest 2001; 107(1): 99-109.
32. Rhee SH, Im E, Riegler M, et al. Pathophysiological role of Tolllike receptor 5 engagement by bacterial flagellin in colonic inflammation. Proc Natl Acad Sci USA 2005; 102(38): 13610-5.
33. Ewaschuk JB, Backer JL, Churchill TA, et al. Surface expression of Toll-like receptor 9 is upregulated on intestinal epithelial cells in response to pathogenic bacterial DNA. Infect Immun 2007; 75(5): 2572-9.
34. Lee J, Mo JH, Katakura K, et al. Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nat Cell Biol 2006; 8(12): 1327-U7.
35. Akhtar M, Watson JL, Nazli A, et al. Bacterial DNA evokes epithelial IL-8 production by a MAPK-dependent, NF-kappaBindependent pathway. FASEB J 2003; 17(10): 1319-21.
36. Cario E, Gerken G, Podolsky DK. Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C. Gastroenterology 2004; 127(1): 224-38.
37. Gibson DL, Ma C, Rosenberger CM, et al. Toll-like receptor 2 plays a critical role in maintaining mucosal integrity during Citrobacter rodentium-induced colitis. Cell Microbiol 2008; 10(2): 388- 403.
38. Slack E, Hapfelmeier S, Stecher B, et al. Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism. Science 2009; 325(5940): 617-20.
39. Cario E, Gerken G, Podolsky DK. Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology 2007; 132(4): 1359-74.
40. Clarke TB, Francella N, Huegel A, et al. Invasive bacterial pathogens exploit TLR-mediated downregulation of tight junction components to facilitate translocation across the epithelium. Cell Host Microbe 2011; 9(5): 404-14.
41. Guo XH, Qiu J, Tu T, et al. Induction of Innate Lymphoid Cell- Derived Interleukin-22 by the Transcription Factor STAT3 Mediates Protection against Intestinal Infection. Immunity 2014; 40(1): 25-39.
42. Sodhi C, Levy R, Gill R, et al. DNA attenuates enterocyte Toll-like receptor 4-mediated intestinal mucosal injury after remote trauma. Am J Physiol Gastrointestinal Liver Physiol 2011; 300(5): G862- 73.
43. Tsung A, Sahai R, Tanaka H, et al. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med 2005; 201(7): 1135-43.
44. Knights AJ, Funnell AP, Crossley M, et al. Holding tight: cell junctions and cancer spread. Trends Cancer Res 2012; 8: 61-9.
45. Araki A, Kanai T, Ishikura T, et al. MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis. J Gastroenterol 2005; 40(1): 16-23.
46. Fukata M, Michelsen KS, Eri R, et al. Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis. Am J Physiol Gastrointestinal Liver Physiol 2005; 288(5): G1055-65.
47. Khailova L, Patrick MSK, Arganbright KM, et al. Bifidobacterium bifidum reduces apoptosis in the intestinal epithelium in necrotizing enterocolitis. Am J Physiol Gastrointestinal Liver Physiol 2010; 299(5): G1118-27.
48. Ciorba MA, Riehl TE, Rao MS, et al. Lactobacillus probiotic protects intestinal epithelium from radiation injury in a TLR-2/cyclooxygenase- 2-dependent manner. Gut 2012; 61(6): 829-38.
49. Brown SL, Riehl TE, Walker MR, et al. Myd88-dependent positioning of Ptgs2-expressing stromal cells maintains colonic epithelial proliferation during injury. J Clin Invest 2007; 117(1): 258-69.
50. Fukata M, Chen A, Klepper A, et al. Cox-2 is regulated by Tolllike receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine. Gastroenterology 2006; 131(3): 862-77.
51. Fukata M, Abreu MT. Role of Toll-like receptors in gastrointestinal malignancies. Oncogene 2008; 27(2): 234-43.
52. Gupta RB, Harpaz N, Itzkowitz S, et al. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology 2007; 133(4): 1099-105; quiz 340-1.
53. Rutter M, Saunders B, Wilkinson K, et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 2004; 126(2): 451-9.
54. Rakoff-Nahoum S, Medzhitov R. Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88. Science 2007; 317(5834): 124-7.
55. Fukata M, Chen A, Vamadevan AS, et al. Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Gastroenterology 2007; 133(6): 1869-81.
56. Fukata M, Hernandez Y, Conduah D, et al. Innate immune signaling by Toll-like receptor-4 (TLR4) shapes the inflammatory microenvironment in colitis-associated tumors. Inflammat Bowel Diseases 2009; 15(7): 997-1006.
57. Shao J, Lee SB, Guo H, et al. Prostaglandin E2 stimulates the growth of colon cancer cells via induction of amphiregulin. Cancer Res 2003; 63(17): 5218-23.
58. Coffey RJ, Hawkey CJ, Damstrup L, et al. Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells. Proc Natl Acad Sci USA 1997; 94(2): 657-62.
59. Li XX, Sun GP, Meng J, et al. Role of toll-like receptor 4 in colorectal carcinogenesis: a meta-analysis. PLoS One 2014; 9(4): e93904.
60. Wang R, Guo L, Wang P, et al. Chemoprevention of cancers in gastrointestinal tract with cyclooxygenase 2 inhibitors. Curr Pharm Des 2013; 19(1): 115-25.
61. Arthur JC, Perez-Chanona E, Muhlbauer M, et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 2012; 338(6103): 120-3.
62. Klimosch SN, Forsti A, Eckert J, et al. Functional TLR5 genetic variants affect human colorectal cancer survival. Cancer Res 2013; 73(24): 7232-42.
63. Castro FA, Forsti A, Buch S, et al. TLR-3 polymorphism is an independent prognostic marker for stage II colorectal cancer. Eur J Cancer 2011; 47(8): 1203-10.
64. Arbour NC, Lorenz E, Schutte BC, et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000; 25(2): 187-91.
65. Tahara T, Arisawa T, Wang F, et al. Toll-like receptor 2 -196 to 174del polymorphism influences the susceptibility of Japanese people to gastric cancer. Cancer Sci 2007; 98(11): 1790-4.
66. Zhou P, Fan L, Yu KD, et al. Toll-like receptor 3 C1234T may protect against geographic atrophy through decreased dsRNA binding capacity. FASEB J 2011; 25(10): 3489-95.
67. Correa P. Human gastric carcinogenesis - a multistep and multifactorial process - 1st american-cancer-society award lecture on cancer- epidemiology and prevention. Cancer Res 1992; 52(24): 6735- 40.
68. Ishihara S, Rumi MA, Kadowaki Y, et al. Essential role of MD-2 in TLR4-dependent signaling during Helicobacter pylori-associated gastritis. J Immunol 2004; 173(2): 1406-16.
69. Chang YJ, Wu MS, Lin JT, et al. Helicobacter pylori-induced invasion and angiogenesis of gastric cells is mediated by cyclooxygenase- 2 induction through TLR2/TLR9 and promoter regulation. J Immunol 2005; 175(12): 8242-52.
70. Smith MF, Mitchell A, Li GL, et al. Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are required for Helicobacter pylori-induced NF-kappa B activation and chemokine expression by epithelial cells. J Biol Chem 2003; 278(35): 32552-60.
71. Mandell L, Moran AP, Cocchiarella A, et al. Intact gram-negative Helicobacter pylori, Helicobacter felis, and Helicobacter hepaticus bacteria activate innate immunity via toll-like receptor 2 but not toll-like receptor 4. Infect immun 2004; 72(11): 6446-54.
72. Greten FR, Eckmann L, Greten TF, et al. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 2004; 118(3): 285-96.
73. Atherfold PA, Jankowski JA. Molecular biology of Barrett's cancer. Best Practice Res Clin Gastroenterol 2006; 20(5): 813-27.
74. Wilson KT, Fu S, Ramanujam KS, et al. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas. Cancer Res 1998; 58(14): 2929-34.
75. Zhang YL, Wang QY, Ma AL, et al. Functional expression of TLR9 in esophageal cancer. Oncol Reports 2014; 31(5): 2298-304.
76. Song X, Gao H, Lin Y, et al. Alterations in the microbiota drive interleukin-17C production from intestinal epithelial cells to promote tumorigenesis. Immunity 2014; 40(1): 140-52.
77. Kennedy CL, Najdovska M, Tye H, et al. Differential role of MyD88 and Mal/TIRAP in TLR2-mediated gastric tumourigenesis. Oncogene 2014; 33(19): 2540-6.
78. Tye H, Kennedy CL, Najdovska M, et al. STAT3-Driven Upregulation of TLR2 Promotes Gastric Tumorigenesis Independent of Tumor Inflammation. Cancer Cell 2012; 22(4): 466-78.
79. Koch M, Mollenkopf HJ, Klemm U, et al. Induction of microRNA- 155 is TLR- and type IV secretion system-dependent in macrophages and inhibits DNA-damage induced apoptosis. Proc Natl Acad Sci USA 2012; 109(19): E1153-62.
80. Ding SZ, Torok AM, Smith MF, Jr., et al. Toll-like receptor 2- mediated gene expression in epithelial cells during Helicobacter pylori infection. Helicobacter 2005; 10(3): 193-204.
81. Grivennikov SI, Wang K, Mucida D, et al. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature 2012; 491(7423): 254-8.
82. Caramalho I, Lopes-Carvalho T, Ostler D, et al. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J Exp Med 2003; 197(4): 403-11.
83. Crellin NK, Garcia RV, Hadisfar O, et al. Human CD4(+) T cells express TLR5 and its ligand flagellin enhances the suppressive capacity and expression of FOXP3 in CD4(+)CD25(+) T regulatory cells. J Immunol 2005; 175(12): 8051-9.
84. Kubo T, Hatton RD, Oliver J, et al. Regulatory T cell suppression and anergy are differentially regulated by proinflammatory cytokines produced by TLR-activated dendritic cells. J Immunol 2004; 173(12): 7249-58.
85. Huang B, Zhao J, Li H, et al. Toll-like receptors on tumor cells facilitate evasion of immune surveillance. Cancer Res 2005; 65(12): 5009-14.
86. Kay E, Scotland RS, Whiteford JR. Toll-like receptors: Role in inflammation and therapeutic potential. Biofactors 2014; 40(3): 284-94.
87. Farhat K, Riekenberg S, Heine H, et al. Heterodimerization of TLR2 with TLR1 or TLR6 expands the ligand spectrum but does not lead to differential signaling. J Leukoc Biol 2008; 83(3): 692- 701.
88. Jin MS, Kim SE, Heo JY, et al. Crystal structure of the TLR1- TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 2007; 130(6): 1071-82.
89. Sandor F, Latz E, Re F, et al. Importance of extra- and intracellular domains of TLR1 and TLR2 in NF kappa B signaling. J Cell Biol 2003; 162(6): 1099-110.
90. Asea A, Rehli M, Kabingu E, et al. Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J Biol Chem 2002; 277(17): 15028-34.
91. Castano-Rodriguez N, Kaakoush NO, Pardo AL, et al. Genetic polymorphisms in the Toll-like receptor signalling pathway in Helicobacter pylori infection and related gastric cancer. Hum Immunol 2014; 75(8): 808-15.
92. Massari P, Henneke P, Ho Y, et al. Cutting edge: Immune stimulation by neisserial porins is toll-like receptor 2 and MyD88 dependent. J Immunol 2002; 168(4): 1533-7.
93. Ozinsky A, Underhill DM, Fontenot JD, et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors. Proc Natl Acad Sci USA 2000; 97(25): 13766-71.
94. Park JS, Svetkauskaite D, He Q, et al. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 2004; 279(9): 7370-7.
95. Schwandner R, Dziarski R, Wesche H, et al. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem 1999; 274(25): 17406-9.
96. Slattery ML, Herrick JS, Bondurant KL, et al. Toll-like receptor genes and their association with colon and rectal cancer development and prognosis. Int J Cancer 2012; 130(12): 2974-80.
97. Takeuchi O, Hoshino K, Kawai T, et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 1999; 11(4): 443-51.
98. Yang CA, Scheibenbogen C, Bauer S, et al. A frequent Toll-like receptor 1 gene polymorphism affects NK- and T-cell IFN-gamma production and is associated with Helicobacter pylori-induced gastric disease. Helicobacter 2013; 18(1): 13-21.
99. Alexopoulou L, Holt AC, Medzhitov R, et al. Recognition of double- stranded RNA and activation of NF-kappa B by Toll-like receptor 3. Nature 2001; 413(6857): 732-8.
100. Fernandez-Garcia B, Eiro N, Gonzalez-Reyes S, et al. Clinical significance of toll-like receptor 3, 4, and 9 in gastric cancer. J Immunother 2014; 37(2): 77-83.
101. Nojiri K, Sugimoto K, Shiraki K, et al. The expression and function of Toll-like receptors 3 and 9 in human colon carcinoma. Oncol Rep 2013; 29(5): 1737-43.
102. Castano-Rodriguez N, Kaakoush NO, Goh KL, et al. The role of TLR2, TLR4 and CD14 genetic polymorphisms in gastric carcinogenesis: a case-control study and meta-analysis. PLoS One 2013; 8(4): e60327.
103. Kawasaki K, Akashi S, Shimazu R, et al. Mouse toll-like receptor 4 center dot MD-2 complex mediates lipopolysaccharide-mimetic signal transduction by taxol. J Biol Chem 2000; 275(4): 2251-4.
104. Kurt-Jones EA, Popova L, Kwinn L, et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 2000; 1(5): 398-401.
105. Ohashi K, Burkart V, Flohe S, et al. Heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 2000; 164(2): 558-61.
106. Okamura Y, Watari M, Jerud ES, et al. The extra domain A of fibronectin activates toll-like receptor 4. J Biol Chem 2001; 276(13): 10229-33.
107. Oliveira AC, Peixoto JR, de Arruda LB, et al. Expression of functional TLR4 confers proinflammatory responsiveness to Trypanosama cruzi glycoinositolphospholipids and higher resistance to infection with T-cruzi. J Immunol 2004; 173(9): 5688-96.
108. Poltorak A, He XL, Smirnova I, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science 1998; 282(5396): 2085-8.
109. Rassa JC, Meyers JL, Zhang YM, et al. Murine retroviruses activate B cells via interaction with toll-like receptor 4. Proc Natl Acad Sci USA 2002; 99(4): 2281-6.
110. Sasu S, LaVerda D, Qureshi N, et al. Chlamydia pneumoniae and chlamydial heat shock protein 60 stimulate proliferation of human vascular smooth muscle cells via Toll-like receptor 4 and p44/p42 mitogen-activated protein kinase activation. Circ Res 2001; 89(3): 244-50.
111. Smiley ST, King JA, Hancock WW. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol 2001; 167(5): 2887-94.
112. Tada H, Nemoto E, Shimauchi H, et al. Saccharomyces cerevisiaeand Candida albicans-derived mannan induced production of tumor necrosis factor alpha by human monocytes in a CD14-and Toll-like receptor 4-dependent manner. Microbiol Immunol 2002; 46(7): 503-12.
113. Termeer C, Benedix F, Sleeman J, et al. Oligosaccharides of hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 2002; 195(1): 99-111.
114. Zhai Y, Shen XD, O'Connell R, et al. Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway. J Immunol 2004; 173(12): 7115-9.
115. Zhou Q, Wang CC, Wang XF, et al. Association between TLR4 (+896A/G and+1196C/T) polymorphisms and gastric cancer risk: an updated meta-analysis. PLoS One 2014; 9(10): 11.
116. Hayashi F, Smith KD, Ozinsky A, et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 2001; 410(6832): 1099-103.
117. Zeng HM, Pan KF, Zhang Y, et al. Genetic variants of toll-like receptor 2 and 5, helicobacter pylori infection, and risk of gastric cancer and its precursors in a chinese population. Cancer Epidemiol Biomarkers Prevent 2011; 20(12): 2594-602.
118. Grimm M, Kim M, Rosenwald A, et al. Toll-like receptor (TLR) 7 and TLR8 expression on CD133+ cells in colorectal cancer points to a specific role for inflammation-induced TLRs in tumourigenesis and tumour progression. Eur J Cancer 2010; 46(15): 2849-57.
119. Heil F, Ahmad-Nejad P, Hemmi H, et al. The toll-like receptor 7 (TLR7)-specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily. Eur J Immunol 2003; 33(11): 2987-97.
120. Heil F, Hemmi H, Hochrein H, et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004; 303(5663): 1526-9.
121. Hemmi H, Kaisho T, Takeuchi O, et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol 2002; 3(2): 196-200.
122. Gorden KKB, Qiu XX, Binsfeld CCA, et al. Cutting edge: Activation of murine TLR8 by a combination of imidazoquinoline immune response modifiers and polyT oligodeoxynucleotides. J Immunol 2006; 177(10): 6584-7.
123. Coban C, Ishii KJ, Kawai T, et al. Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin. J Exp Med 2005; 201(1): 19-25.
124. Furi I, Sipos F, Germann TM, et al. Epithelial toll-like receptor 9 signaling in colorectal inflammation and cancer: clinico-pathogenic aspects. World J Gastroenterol 2013; 19(26): 4119-26.
125. Hemmi H, Takeuchi O, Kawai T, et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000; 408(6813): 740-5.
126. Krug A, Towarowski A, Britsch S, et al. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur J Immunol 2001; 31(10): 3026- 37.
127. Wang TR, Peng JC, Qiao YQ, et al. Helicobacter pylori regulates TLR4 and TLR9 during gastric carcinogenesis. Int J Clin Exp Pathol 2014; 7(10): 6950-5.
128. Tsujimoto H, Uchida T, Efron PA, et al. Flagellin enhances NK cell proliferation and, activation directly and through dendritic cell- NK cell interactions. J Leukoc Biol 2005; 78(4): 888-97.
129. Zhang DK, Zhang GL, Hayden MS, et al. A toll-like receptor that prevents infection by uropathogenic bacteria. Science 2004; 303(5663): 1522-6.